Silence Therapeutics — siRNA drugs
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Paul Tudor Jones / Tudor | 61 | New buy | 44,252 | $483,674 | 0.0% |
| Steve Cohen / Point72 | 75 | New buy | 40,192 | $439,299 | 0.0% |
| George Soros / Soros Fund Mgmt | 33 | New buy | 100,000 | $1,093,000 | 0.0% |
| Report | Date | Stance |
|---|---|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | LONG |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.